Phase3,Open-label,Long-term,NSAID-Add-on,Clinical Trial of Mono-phase Low-dose Oral Contraceptive Pill for Treatment of Dysmenorrhea Associated With Endometriosis.

Nobelpharma0 个研究点开始时间: 2005年2月1日最近更新: 2010年9月10日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

The purpose of this long-term study is to determine whether combination oral contraceptive pill of Norethindrone & Ethinyl estradiol is effective in the treatmentof dysmenorrhea associated with endometriosis.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: Female
接受健康志愿者: 否

入选标准

•dysmenorrhea associated with endometriosis

排除标准

•severe hepatopathy
•pregnant woman

研究者

发起方

Nobelpharma

申办方类型

Industry

相似试验

已完成

3 期

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary DysmenorrheaDysmenorrhea

NCT00746096Nobelpharma115

已完成

3 期

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat DysmenorrheaDysmenorrhea

NCT00212342Nobelpharma100

已完成

3 期

Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral ContraceptionContraception

NCT00245921Wyeth is now a wholly owned subsidiary of Pfizer2,000

已完成

3 期

Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and HeadacheOral ContraceptiveHeadachePelvic Pain

NCT00778609Bayer449

已完成

3 期

Effects on Hemostasis, Lipids, Carbohydrate Metabolism, Adrenal & Thyroid Function of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing LNG-EE (292004)(COMPLETED)(P05764)Contraception

NCT00511355Organon and Co121